We have shown that SMO inhibitor cyclopamine and GLI inhibitor GANT61 are both able to down regulate SOX18 expression in HeLa cells, opening a new field of potential manipulation with this gene expression in cancer. This evidence concerns the gene GLI1 and cancer.